CSIMarket
 

Vyne Therapeutics Inc   (VYNE)
Other Ticker:  
 

Vyne Therapeutics Inc 's Working Capital Per Sales

VYNE's Working Capital and Revenue growth



VYNE Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change 203.49 % -70.43 % -63.45 % -51.33 % -34.93 %
Y / Y Revenue Change 1166.67 % -31.74 % 7.14 % -44.38 % -99.74 %
Working Capital Per Revenue 83.48 58.11 66.73 86.32 86.12
Total Ranking # 2066 # 0 # 0 # 0 # 0
Seq. Working Capital Change 699.36 % -33.3 % -34.97 % -12.47 % -22.13 %
Seq. Revenue Change -33.33 % -15.56 % 36.36 % 1550 % -96.41 %





Comment on VYNE's Working Capital Per Revenue in the fourth quarter 2023
Vyne Therapeutics Inc 's Working Capital Per Revenue sequentially grew to 83.48 during the Q4 2023, a new company high.

Within Healthcare sector 205 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Working Capital Per Revenue total ranking has deteriorated in the fourth quarter 2023, compared to previous quarter from 0 to 2066.
Working Capital Per Revenue Ranking
Within: No.
Industry # 60
Sector # 206
S&P 500 # 2066


Working Capital Per Revenue Statistics
High Average Low
83.48
14.75
3.31
(Dec 31 2023)   (Dec 31 2020)



Financial Statements
Vyne Therapeutics Inc 's Working Capital $ 88 Millions Visit VYNE's Balance sheet
Vyne Therapeutics Inc 's Revenues $ 0 Millions Visit VYNE's Income Statement
Where are VYNE's Sales coming from? Visit VYNE's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Sera Prognostics Inc   146.62 
Inhibrx Inc   131.90 
Pluri Inc   95.07 
Vyne Therapeutics Inc   83.48 
Century Therapeutics inc   76.37 
Bioxcel Therapeutics Inc   64.53 
Avidity Biosciences Inc   55.85 
Celldex Therapeutics inc   41.49 
Clene Inc   38.33 
Ngm Biopharmaceuticals Inc   38.02 
Orchestra Biomed Holdings Inc   35.52 
Praxis Precision Medicines Inc   33.26 
Kronos Bio Inc   28.99 
Agios Pharmaceuticals Inc   26.66 
Molecular Partners Ag  25.30 
Sol gel Technologies Ltd   23.58 
Anaptysbio Inc   22.68 
Lumos Pharma Inc   22.19 
Beyond Air Inc   21.87 
Roivant Sciences Ltd   21.69 
Abcellera Biologics Inc   21.20 
Enzon Pharmaceuticals inc   20.35 
Absci Corp  20.04 
Vir Biotechnology Inc   19.18 
Date modified: 2024-03-06T17:25:02+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com